<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:gild="http://gilead.com/20200923">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_021_US%2DGAAP%2D2019 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_gild_gilead.com_20200923 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20200923_20200923 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0000882095 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:EntityCentralIndexKey">0000882095</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="gild-20200923.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-09-23to2020-09-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-23</xbrli:startDate>
        <xbrli:endDate>2020-09-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 16pt"><b>UNITED
STATES</b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 16pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: none; font-size: 16pt"><b>FORM
<span id="xdx_90A_edei--DocumentType_c20200923__20200923_z2ufVnkngzAl"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: capitalize"><b>Current
Report</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of
the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of Earliest Event
Reported): <span id="xdx_90B_edei--DocumentPeriodEndDate_c20200923__20200923_zFS5jrdDrZoj"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">September 23, 2020</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90A_edei--EntityRegistrantName_c20200923__20200923_zpTrKDDyYL85" style="font-size: 22pt; text-transform: capitalize"><b><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:EntityRegistrantName">Gilead
Sciences, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact Name of Registrant as Specified
in its Charter)</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 32%; font-size: 10pt; text-align: center"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20200923__20200923_zp4DhW7WqOD3"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b><b><br />
    (State or Other <br />
Jurisdiction<br />
    of Incorporation)</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 32%; font-size: 10pt; text-align: center"><span id="xdx_901_edei--EntityFileNumber_c20200923__20200923_zrTVSB8UZE29"><b><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:EntityFileNumber">0-19731</ix:nonNumeric></b></span><b><br />
    (Commission File Number)</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="white-space: nowrap; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20200923__20200923_zkaaHFKbm3X1"><b><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:EntityTaxIdentificationNumber">94-3047598</ix:nonNumeric></b></span><b><br />
        (I.R.S. Employer</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding: 0.25pt; width: 49%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_900_edei--EntityAddressAddressLine1_c20200923__20200923_zWl8SD6pSayk"><b><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:EntityAddressAddressLine1">333
Lakeside Drive</ix:nonNumeric></b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span><b></b></span><b><span id="xdx_90F_edei--EntityAddressCityOrTown_c20200923__20200923_zMrS0heYtyHi"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:EntityAddressCityOrTown">Foster City</ix:nonNumeric></span></b><b>,
<span id="xdx_901_edei--EntityAddressStateOrProvince_c20200923__20200923_zX2SgIbKuwBg"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></p></td>
    <td style="width: 2%">&#160;</td>
    <td style="padding: 0.25pt; width: 49%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityAddressPostalZipCode_c20200923__20200923_zDII7fyrYYjh"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:EntityAddressPostalZipCode">94404</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Address of Principal Executive Offices)</b></span></td>
    <td>&#160;</td>
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Zip Code)</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>Registrant&#8217;s
telephone number, including area code:</b> <b>(<span id="xdx_902_edei--CityAreaCode_c20200923__20200923_zJWOhbJuK5id"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:CityAreaCode">650</ix:nonNumeric></span></b></span><b><span style="font-size: 10pt">)
<span id="xdx_906_edei--LocalPhoneNumber_c20200923__20200923_zZaH093HPIql"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:LocalPhoneNumber">574-3000</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="font-size: 10pt">&#160;&#160;</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><b>(Former Name or
Former Address, if Changed Since Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><b></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90C_edei--WrittenCommunications_c20200923__20200923_zeHrQs7l52H1"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>                                                                                                                                                                                                                                                                                                       <tr style="vertical-align: top">
    <td>&#160;</td>
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90B_edei--SolicitingMaterial_c20200923__20200923_zHTBSHBGqDtf"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>                                                                                                                                                                                                                                                                                                     <tr style="vertical-align: top">
    <td>&#160;</td>
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
<td style="width: 0.25in"><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementTenderOffer_c20200923__20200923_zBAmNQ0T8jv4"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 <tr style="vertical-align: top">
    <td>&#160;</td>
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
<td><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20200923__20200923_zUjWww8FpXTg"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center; vertical-align: bottom"><b>Title of Each
    Class</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center; vertical-align: bottom"><b>Trading Symbol(s)</b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center; vertical-align: bottom"><b>Name of Each Exchange on which<br />
    Registered</b></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span id="xdx_908_edei--Security12bTitle_c20200923__20200923_zeixR0S3UWuc"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:Security12bTitle">Common Stock, par
    value $0.001 per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_909_edei--TradingSymbol_c20200923__20200923_zK10Ns9wHc09"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" name="dei:TradingSymbol">GILD</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span id="xdx_901_edei--SecurityExchangeName_c20200923__20200923_zfsP5mBtVIL7"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Global
    Select Market</ix:nonNumeric></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20200923__20200923_zuyq6OyS1hJj"><ix:nonNumeric contextRef="From2020-09-23to2020-09-23" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Underwriting Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On September 23, 2020, Gilead Sciences,
Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Barclays
Capital Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters listed in Schedule 1 thereto, relating
to the issuance and sale by the Company of (a) $500,000,000 aggregate principal amount of the Company&#8217;s Floating Rate Notes
due 2021 (the &#8220;2021 Floating Rate Notes&#8221;), (b) $500,000,000 aggregate principal amount of the Company&#8217;s Floating
Rate Notes due 2023 (the &#8220;2023 Floating Rate Notes&#8221;), (c) $2,000,000,000 aggregate principal amount of the Company&#8217;s
0.750% Senior Notes due 2023 (the &#8220;2023 Fixed Rate Notes&#8221;), (d) $750,000,000 aggregate principal amount of the Company&#8217;s
1.200% Senior Notes due 2027 (the &#8220;2027 Fixed Rate Notes&#8221;), (e) $1,000,000,000 aggregate principal amount of the Company&#8217;s
1.650% Senior Notes due 2030 (the &#8220;2030 Fixed Rate Notes&#8221;), (f) $1,000,000,000 aggregate principal amount of the Company&#8217;s
2.600% Senior Notes due 2040 (the &#8220;2040 Fixed Rate Notes&#8221;), and (g) $1,500,000,000 aggregate principal amount of the
Company&#8217;s 2.800% Senior Notes due 2050 (the &#8220;2050 Fixed Rate Notes&#8221; and, together with the 2021 Floating Rate
Notes, the 2023 Floating Rate Notes, the 2023 Fixed Rate Notes, the 2027 Fixed Rate Notes, the 2030 Fixed Rate Notes and the 2040
Fixed Rate Notes, the &#8220;Notes&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Some of the underwriters and their
affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary
course of business with the Company or its affiliates. They have received, or may in the future receive, customary fees and
commissions for these transactions. In particular, affiliates of certain of the underwriters for this offering are also
lenders under the Company&#8217;s existing revolving credit facility and serve in various agency or other capacities under
such facilities. In addition, affiliates of certain of the underwriters for this offering may become lenders under a new term
loan facility that we may enter into to provide a portion of the financing in connection with the previously announced
acquisition of Immunomedics, Inc. and may serve in various agency or other capacities under such facility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In addition, in the ordinary course of
their business activities, the underwriters and their affiliates may make or hold a broad array of investments and actively trade
debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account
and for the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of
the Company or its affiliates. If any of the underwriters or their affiliates have a lending relationship with the Company, certain
of those underwriters or their affiliates routinely hedge, and certain other of those underwriters or their affiliates may hedge,
their credit exposure to the Company consistent with their customary risk management policies. Typically, these underwriters and
their affiliates would hedge such exposure by entering into transactions which consist of either the purchase of credit default
swaps or the creation of short positions in the Company&#8217;s securities, including potentially the Notes. Any such credit default
swaps or short positions could adversely affect future trading prices of the Notes. The underwriters and their affiliates may also
make investment recommendations and/or publish or express independent research views in respect of such securities or financial
instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Underwriting Agreement is filed herewith
as Exhibit 1.1. The description of the Underwriting Agreement herein is qualified by reference thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;&#160;&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Underwriting Agreement contains representations
and warranties by each of the parties thereto. These representations and warranties have been made solely for the benefit of the
other party or parties to the Underwriting Agreement and:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: 10pt Symbol">&#183;</span></td><td>should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one
or more of the parties if those statements prove to be inaccurate;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: 10pt Symbol">&#183;</span></td><td>may have been qualified by disclosures that were made to the other party or parties in connection with the negotiation of the
Underwriting Agreement, which disclosures are not necessarily reflected in such agreement;</td></tr></table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 2; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: 10pt Symbol">&#183;</span></td><td>may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font: 10pt Symbol">&#183;</span></td><td>were made only as of the date of the Underwriting Agreement or such other date or dates as may be specified in such agreement
and are subject to more recent developments.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Accordingly, these representations and
warranties may not describe the actual state of affairs as of the date they were made or at any other time. The Company acknowledges
that, notwithstanding the inclusion of the foregoing general disclaimer, it is responsible for considering whether additional specific
disclosures of material information regarding material contractual provisions are required to make the statements in this report
not misleading.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Additional
information about the Company may be found elsewhere in this report and the Company&#8217;s other public filings, which are available
without charge through the Securities and Exchange Commission&#8217;s website at <span style="text-decoration: underline">http://www.sec.gov</span></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following exhibits are filed as part of this Current Report
on Form 8-K:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left">Exhibit <br /> Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">Description</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.05in; vertical-align: top; width: 10%; text-align: left"><a href="tm2031940d1_ex1-1.htm">1.1</a></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: left"><a href="tm2031940d1_ex1-1.htm">Underwriting Agreement, dated September 23, 2020, among the Company and Barclays Capital Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters listed in Schedule 1 thereto.</a></td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.05in; vertical-align: top; text-align: left">104</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 3; Value: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif">GILEAD SCIENCES, INC.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">By:</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Andrew D. Dickinson</td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 49%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%; vertical-align: bottom">Name:</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%">Andrew D. Dickinson</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">Title:</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Executive Vice President and Chief Financial Officer</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: September 29, 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5LpqWKto3LSpiFSkivka7SrDNlk38O5K3NLaIy8KyzHwzQoRiQXNdIcNhWuSww7qplEMo8IyM5oTekS1XKfhb4EVbx8q49v2BGXkGPTPoyePJC631ri2WKchRP0760RjkMB0kMFmL4KtnZM66ROO0qkCZErZMDWt0il9dwk49yVD9aqv2yFaTSSHqyU5+QyyjGDZ0Vw/iq4U8z0QQthOIBdOt+dbcrKMaZhXWvst26H+DDzhySXg= -->
